Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03448016 · ClinicalTrials.gov registry record · Early Phase 1

[C-11]NOP-1A and Alcohol Use Disorder

A Early Phase 1 study, sponsored by Rajesh Narendran.

Completed
Registry status
Early Phase 1
Development phase
54
Enrollment target

NCT03448016 is a Early Phase 1 study that has completed, run by Rajesh Narendran. The registered enrollment target is 54 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03448016, a Early Phase 1 study, has completed, sponsored by Rajesh Narendran.

COMPLETED
Registry status
Early Phase 1
Development phase
54 participants
Enrollment target

Study Summary

The goal of this study is to compare \[C-11\]NOP-1A binding in recently abstinent alcohol use disorders and controls

Interventions

  • RADIATION [C-11]
  • DRUG NOP-1A

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2016-05-27
Est. Completion 2021-03-30
Phase Early Phase 1

Sponsor

Rajesh Narendran

5 total trials

What the Registry Record Tells You About NCT03448016

The ClinicalTrials.gov registry entry for NCT03448016 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rajesh Narendran, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which [C-11] is the first listed.

NCT03448016 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03448016 about?

NCT03448016 is a clinical study titled "[C-11]NOP-1A and Alcohol Use Disorder". The goal of this study is to compare \[C-11\]NOP-1A binding in recently abstinent alcohol use disorders and controls

What is the current status of trial NCT03448016?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 54 participants. The study started on 2016-05-27. Estimated completion is 2021-03-30.

What interventions are being tested in trial NCT03448016?

The interventions under investigation include: [C-11] (RADIATION), NOP-1A (DRUG).

Who is sponsoring clinical trial NCT03448016?

This trial is sponsored by Rajesh Narendran, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.